The problem that's caused Intel to initiate a billion-dollar chipset recall affects the SATA ports on all 6-series chipsets, including the H67 and P67 chipsets most prominently used in consumer products. All of these chipsets are collectively referred to as "Cougar Point" inside of Intel. Because there are no third-party chipsets compatible with Sandy Bridge processors, all Sandy Bridge-based systems are potentially affected, including desktops, laptops, and DIY motherboards.
Beside the obvious inconvenience and bad PR, this little slip-up will cost Intel quite a bit of money, too. The firm expects to see a $300-million dent in first-quarter revenue (since full volume production of 6-series chipsets won't resume until April), not to mention $700 million in total repair and replacement costs.With the need for such a major recall Intel is going to lose over a billion dollars in a new chipset, replacing the recalled chipsets, and repairing damage to mother boards and other computer components of the unsuspecting consumers who went out and purchased the new generation of six core processors. This overall will stain the companies image and reliability which will cause a massive drop in sales and a inversely proportional rise in the sales of companies such as AMD. With this change in consumer consumption Intel's first quarter profits for the year will either be extremely low or will even report a loss. Also this puts extra pressure on the company's consumers. Not only do they have to worry about getting their computers in for the recall, they must also worry about replacing them. Most likely causing a almost complete rebuild of their system. Intel's failure to notice this problem during testing could also be related toward the Microsoft Windows Vista failure a year or so back. This just further proves why it is crucial for companies to beta test their products for an extended period of time when working in unfamiliar territories such as 32nm architecture. Yes it will cost them more money up front, but it removes the potential of billion dollar recalls which are detrimental to a company.